Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hemophilia A Research Program (HARP): An Observational Intergenerational Cohort Study of Hemophilia A and Factor VIII Immunogenicity

NCT07414511 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT07414511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07414511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hemophilia A Research Program (HARP): An Observational Intergenerational Cohort Study of Hemophilia A and Factor VIII Immunogenicity
Lead sponsor
University of Washington
Phase
Observational
Overall status
Recruiting
Start date
July 31, 2024
Completion date
August 31, 2029
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alloimmunization, bleeding disorder, carrier of hemophilia a, factor viii (fviii), fviii deficiency, hemophilia a, hemophilia a, severe, hemorrhage, postpartum, inhibitors, maternal blood loss, pregnancy, pregnancy complications, x-linked